Literature DB >> 9603337

Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies.

J A Liljeqvist1, E Trybala, B Svennerholm, S Jeansson, E Sjögren-Jansson, T Bergström.   

Abstract

Glycoprotein G is a major target for the humoral immune response against herpes simplex virus (HSV) and a prototype antigen for type-specific serodiagnosis discriminating HSV-1 and HSV-2 infections. The mature part of HSV-2 glycoprotein G-2 (gG-2) contains a unique stretch suspected to mediate type specificity, and in addition a region homologous to HSV-1 glycoprotein G-1 (gG-1). Antigenic determinants of the mature gG-2 were mapped by testing the reactivity of mouse anti-gG-2 monoclonal antibodies (MAbs) and purified human anti-gG-2 antibodies with synthetic peptides coupled to cellulose membranes. The anti-gG-2 MAbs bound to four epitopes localized in a narrow cluster within a gG-2 segment delimited by amino acids (aa) 552 and 611. This cluster was located between the predicted O-glycan-rich region and the transmembrane anchor sequence. The epitopes of the human anti-gG-2 antibodies were localized within three stretches of amino acids, two of which were overlapping with those recognized by anti-gG-2 MAbs. One of these stretches, delimited by aa 552 and 574, showed reactivity to all human HSV-2 sera tested, but not to HSV-1 sera or to purified anti-gG-1 antibodies. Neither the anti-gG-2 MAbs nor the purified human anti-gG-2 antibodies were cross-reactive to gG-1 peptides or HSV-1 antigen, although most of the epitopes were localized within the part of gG-2 which was homologous to gG-1. The findings concerning HSV-2 type-specific human antibody response to a defined stretch within gG-2 may be of importance for the further development of type-discriminating serodiagnosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603337     DOI: 10.1099/0022-1317-79-5-1215

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

1.  Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay.

Authors:  S Q Wales; C C Smith; M Wachsman; G Calton; L Aurelian
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

2.  Prevalence of antibodies against herpes simplex virus types 1 and 2 in children and young people in an urban region in Tanzania.

Authors:  Mabula Joseph Kasubi; Arvid Nilsen; Howard S Marsden; Tomas Bergström; Nina Langeland; Lars Haarr
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

3.  Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2.

Authors:  Bodo Rolf Eing; Lars Lippelt; Eva Ulla Lorentzen; Wali Hafezi; Wolfgang Schlumberger; Katja Steinhagen; Joachim Ewald Kühn
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

4.  Conservation of type-specific B-cell epitopes of glycoprotein G in clinical herpes simplex virus type 2 isolates.

Authors:  J A Liljeqvist; B Svennerholm; T Bergström
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

Review 5.  Diagnostics for herpes simplex virus: is PCR the new gold standard?

Authors:  Lara B Strick; Anna Wald
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

6.  Discrimination of antibody to herpes B virus from antibody to herpes simplex virus types 1 and 2 in human and macaque sera.

Authors:  Akikazu Fujima; Yoshitsugu Ochiai; Aya Saito; Yuki Omori; Atsuya Noda; Yukumasa Kazuyama; Hiroshi Shoji; Kiyoshi Tanabayashi; Fukiko Ueda; Yasuhiro Yoshikawa; Ryo Hondo
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

7.  Dichotomy of glycoprotein g gene in herpes simplex virus type 1 isolates.

Authors:  Elham Rekabdar; Petra Tunbäck; Jan-Ake Liljeqvist; Magnus Lindh; Tomas Bergström
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

8.  Seroprevalences of herpes simplex virus type 2, five oncogenic human papillomaviruses, and Chlamydia trachomatis in Katowice, Poland.

Authors:  Staffan Görander; Teresa Lagergård; Malgorzata Romanik; Raphael P Viscidi; Gayane Martirosian; Jan-Ake Liljeqvist
Journal:  Clin Vaccine Immunol       Date:  2008-02-20

Review 9.  Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection.

Authors:  Jairam R Lingappa; Connie Celum
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Human monoclonal antibody fragment specific for glycoprotein G in herpes simplex virus type 2 with applications for serotype-specific diagnosis.

Authors:  Francesca Bugli; Stefania Manzara; Riccardo Torelli; Rosalia Graffeo; Rosaria Santangelo; Paola Cattani; Giovanni Fadda
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.